RESEARCH PEPTIDE FUNDAMENTALS
Every Peptide Has a Job. This Is What Each One Does.
A functional-roles review of five widely studied research peptides — tissue-level anti-inflammatory signaling, mitochondrial metabolism, neuroendocrine desire, whole-body metabolic regulation, and thymic immune priming — read against the primary literature.
KPV
A three-amino-acid fragment of a natural anti-inflammatory hormone, studied for calming gut inflammation in animal models without the pigment-darkening action of its parent molecule.
Read the review →
MOTS-c
A 16-amino-acid peptide encoded directly in mitochondrial DNA, studied for activating AMPK and improving metabolic and exercise-performance markers in animal models.
Read the review →
PT-141
The research designation for bremelanotide, an FDA-approved melanocortin-receptor agonist studied for hypoactive sexual desire disorder in premenopausal women.
Read the review →
Retatrutide
An investigational triple hormone-receptor agonist studied in Phase 2 and Phase 3 trials for its effect on body weight, glucose control, and liver fat.
Read the review →
Thymosin Alpha-1
The lead compound on this desk — a 28-amino-acid thymic peptide approved as a drug in dozens of countries and studied across sepsis, viral infection, and oncology.
Read the review →Abstract — the short version
Peptides Jobs is a functional-roles review, not a shopping guide. Research Peptide Fundamentals research peptides are short chains of amino acids — the same building blocks that make up every protein in the body, only far smaller — that carry out a specific job: a defined biological task somewhere in the body's signaling machinery. Despite the site's name, this is not an employment site; 'Jobs' refers to the biological work each peptide does, not a listing of positions to apply for.
This desk covers five peptides that, taken together, sample five distinct functional roles: KPV (anti-inflammatory signaling at the gut lining), MOTS-c (mitochondrial metabolic signaling), PT-141 (neuroendocrine sexual-desire signaling), retatrutide (metabolic hormone-receptor agonism), and thymosin alpha-1, the lead compound (thymic immune modulation). Each has its own review page, cited to the primary and review literature. None of this is medical advice, and no page here recommends a dose for any person.
What each peptide's job is: functional roles by class
The organizing idea on this desk is not chemical family but functional job — the specific task a peptide performs in the body's signaling network. Grouping compounds this way surfaces a different picture than grouping them by structure alone: a small tripeptide (KPV) and a much larger triple-receptor agonist (retatrutide) can occupy entirely different tiers of biology, one acting locally at a tissue barrier, the other acting on whole-body energy balance.
Reading the five side by side clarifies what a job means at the molecular level: a receptor switched on, a transporter engaged preferentially at a site of injury, an enzyme activated, a transcription factor turned on or suppressed. KPV's job is narrowly local — anti-inflammatory signaling at the gut lining. MOTS-c's job is intracellular — mitochondrial energy metabolism. PT-141's job is central-nervous-system signaling for sexual motivation. Retatrutide's job is the broadest in physical scope — whole-body metabolic hormone regulation across three receptors at once. Thymosin alpha-1's job, as the lead compound, is systemic — priming and rebalancing the adaptive immune system. See the full comparison for how the five line up side by side.
What are research peptides?
Peptides are chains of amino acids distinguished from full proteins mainly by length — typically fewer than 50 residues. Some of the compounds reviewed here are naturally occurring fragments of larger hormones: KPV is the last three residues of alpha-melanocyte-stimulating hormone (alpha-MSH), and PT-141 is a cyclic analogue built on the same alpha-MSH scaffold. Others are engineered from scratch: retatrutide is a synthetic 39-residue molecule designed to engage three separate hormone receptors with an extended circulating half-life. Thymosin alpha-1 was originally isolated directly from thymic tissue and is now manufactured identically as a synthetic drug. MOTS-c is unusual among all of them because its blueprint sits in mitochondrial DNA rather than the cell nucleus.
The regulatory spectrum across these five is wide, and this desk states it plainly on every page rather than blurring it: bremelanotide, the pharmaceutical name for PT-141, is FDA-approved for one specific indication [15]; thymosin alpha-1 is approved as a drug in dozens of other countries but not in the United States [22]; retatrutide is investigational, with Phase 3 trials still underway [16]; and KPV and MOTS-c are laboratory research chemicals with no approved human use anywhere.
How this desk reads the evidence
Every claim on this site is tied to a numbered citation on the references page, and every page states the species, sample size, and phase of evidence behind a finding rather than presenting it as settled fact. 'Research Peptide Fundamentals' does not mean 'equally proven' — evidence quality varies enormously across these five compounds, from large randomized Phase 3 trials down to cell-culture assays with no human data at all, and each compound page names exactly where its evidence sits on that ladder.
Where community members describe an effect from personal use, that material is presented separately and labeled explicitly as anecdotal, never blended with the cited clinical or preclinical findings above it. No page on this site recommends a dose, a use, or a course of action for any individual; where a dose appears, it is the dose used in a cited study or specified on an approved product label, reported as history, not instruction.